Application Note

Sterilizing Filtration During Small Molecule Drug Formulation And Filling

By Critical Process Filtration

drug-production-small-mole-GettyImages-2278072672

Maintaining sterility during small molecule drug formulation and filling requires more than a single filtration step. Effective contamination control combines preventive barriers with remediation strategies to address bacteria introduced through raw materials, water systems, or the manufacturing environment. Because these risks cannot be fully eliminated, filtration plays a critical role in removing microorganisms and protecting both product quality and patient safety.

A multi-stage approach ensures reliable performance, with upstream bioburden reduction filters minimizing microbial load before the final sterilizing filter. This helps prevent premature fouling, which can disrupt batch processes and increase operational costs.At the final stage, validated membrane filters — typically rated at 0.22 microns or smaller — provide the assurance needed to meet stringent pharmaceutical standards.

Understanding how these filtration layers work together enables manufacturers to maintain process efficiency while safeguarding product integrity throughout formulation and filling.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online